Luminex Corp to Acquire EraGen Biosciences Inc
Luminex will purchase all outstanding shares of EraGen for approximately $34 million in cash, subject to certain adjustments.
Read MorePosted by Clinical Lab Products | Jul 7, 2011 | Uncategorized |
Luminex will purchase all outstanding shares of EraGen for approximately $34 million in cash, subject to certain adjustments.
Read MorePosted by Clinical Lab Products | Jun 20, 2011 | Molecular Diagnostics |
Forty-four managed care organizations have licensed McKesson’s molecular and genetic diagnostic management solutions.
Read MorePosted by Clinical Lab Products | Jun 14, 2011 | Cancer, Miscellaneous |
The agreement is a foundational element in the planned Cancer Genome Institute at Fox Chase Cancer Center.
Read MorePosted by Clinical Lab Products | Jun 1, 2011 | Cancer, Miscellaneous |
Scientists at Dana-Farber Cancer Institute have identified an overactive network of growth-spurring genes that drive stem-like breast cancer cells enriched in triple-negative breast tumors.
Read MorePosted by Clinical Lab Products | May 17, 2011 | Miscellaneous |
Gen-Probe will commercialize future sequencing-based diagnostic assays and fragment analysis-based human diagnostic genetic tests to be used on the Life Technologies 3500 Dx Series Genetic Analyzers.
Read More